Ammonia → HCID 178461178, compound
Reaction equation
[CH3:1][C@H:2]1[CH2:7][CH2:6][CH2:5][CH2:4][N:3]1[C@H:8]1[CH2:11][C@H:10]([C:12]2[S:13][C:14]3[CH:20]=[C:19]([C:21]([OH:23])=O)[CH:18]=[CH:17][C:15]=3[N:16]=2)[CH2:9]1.C(Cl)(=O)C(Cl)=O.C[N:31](C=O)C.N>C(Cl)Cl>[CH3:1][C@H:2]1[CH2:7][CH2:6][CH2:5][CH2:4][N:3]1[C@H:8]1[CH2:11][C@H:10]([C:12]2[S:13][C:14]3[CH:20]=[C:19]([C:21]([NH2:31])=[O:23])[CH:18]=[CH:17][C:15]=3[N:16]=2)[CH2:9]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
2-{trans-3-[(S)-2-methylpiperidin-1-yl]cyclobutyl}-1,3-benzothiazole-6-carboxylic acid (Example 143B, 20 mg, 0.062 mmol) was added to a solution of oxalyl chloride (17 mg, 0.13 mmol) in CH2Cl2 (1 mL) at 23° C., followed by 1 drop of catalytic amount of DMF. The reaction mixture was allowed to stir for 1 h. Solvent and excess of oxalyl chloride were removed under vacuum, the residue solid was re-dissolved in CH2Cl2 (0.5 mL). Excess of ammonia (2 mL, 1.2 mmol) in CH2Cl2 (2 mL) was then added to the reaction vial. The reaction mixture was then stirred overnight. Solvent was removed, and the crude product was purified via HPLC (C-18 column, 0.1% TFA in acetonitrile) to give 16 mg product as a TFA salt (65%). 1H NMR (500 MHz, CD3OD): δ=8.51 ppm (m, 1H), 8.01 (m, 2H), 4.00 (m, 1H), 3.80 (m, 1H), 3.83 (m, 2H), 2.80-3.15 (m, 5H), 2.74 (m, 1H), 1.94 (m, 3H), 1.75 (m, 3H), 1.41 (m, 3H). MS (ESI, M+H+): 330.0.
Workup
- customSolvent and excess of oxalyl chloride were removed under vacuum
- dissolutionthe residue solid was re-dissolved in CH2Cl2 (0.5 mL)
- stirringThe reaction mixture was then stirred overnight
- customSolvent was removed
- customthe crude product was purified via HPLC (C-18 column, 0.1% TFA in acetonitrile)
Sources & evidence
- ORD record
- ord-3e8ac9940a64412089657f7f03f3e105
- Source dataset
- uspto-grants-2009_08
- Patent number
- US07576110B2
Reaction notes
Loading…